Applied Opt (AAOI) had the highest return between June 13, 2023 and August 30, 2023 by a small-cap US stock, returning 364%.
| ASSET | DATE | % RETURN |
|---|---|---|
Applied Opt (AAOI) | 6/13/2023 - 8/30/2023 | 364.02% |
Spyre Therapeutics (SYRE) | 6/13/2023 - 8/30/2023 | 305.71% |
Taysha Gene Therapies (TSHA) | 6/13/2023 - 8/30/2023 | 283.63% |
Innoviz Technologies (INVZW) | 6/13/2023 - 8/30/2023 | 233.33% |
ASP Isotopes Inc Common Stock (ASPI) | 6/13/2023 - 8/30/2023 | 209.52% |
Akso Health Group ADR (AHG) | 6/13/2023 - 8/30/2023 | 170.49% |
Gyre Therapeutics (GYRE) | 6/13/2023 - 8/30/2023 | 133.42% |
Groupon (GRPN) | 6/13/2023 - 8/30/2023 | 131.55% |
Telesat (TSAT) | 6/13/2023 - 8/30/2023 | 112.53% |
Vera Therapeutics (VERA) | 6/13/2023 - 8/30/2023 | 110.79% |
Neuropace (NPCE) | 6/13/2023 - 8/30/2023 | 109.49% |
Root (ROOT) | 6/13/2023 - 8/30/2023 | 95.81% |
Oncology Institute (TOI) | 6/13/2023 - 8/30/2023 | 94.98% |
Tetra Technologies (TTI) | 6/13/2023 - 8/30/2023 | 92.04% |
Pharvaris (PHVS) | 6/13/2023 - 8/30/2023 | 87.49% |
Tango Therapeutics (TNGX) | 6/13/2023 - 8/30/2023 | 86.27% |
Fulcrum Therapeutics (FULC) | 6/13/2023 - 8/30/2023 | 85.86% |
Orion (ORN) | 6/13/2023 - 8/30/2023 | 81.64% |
Nanobiotix (NBTX) | 6/13/2023 - 8/30/2023 | 76.98% |
Eyepoint Pharmaceuticals (EYPT) | 6/13/2023 - 8/30/2023 | 73.63% |
Waldencast Acquisition (WALDW) | 6/13/2023 - 8/30/2023 | 70% |
GigaCloud Technology Inc Class A Ordinary Shares (GCT) | 6/13/2023 - 8/30/2023 | 68.8% |
Sify Technologies (SIFY) | 6/13/2023 - 8/30/2023 | 59.85% |
Acm Research (ACMR) | 6/13/2023 - 8/30/2023 | 59.68% |
Oric Pharmaceuticals (ORIC) | 6/13/2023 - 8/30/2023 | 58.3% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
